首页 | 本学科首页   官方微博 | 高级检索  
检索        

胰激肽原酶联合甲钴胺治疗糖尿病周围神经病变80例临床分析
引用本文:周雪红,赵彦民,王凯.胰激肽原酶联合甲钴胺治疗糖尿病周围神经病变80例临床分析[J].中国实用神经疾病杂志,2011,14(4):21-22.
作者姓名:周雪红  赵彦民  王凯
作者单位:河南焦作市第二人民医院内分泌科,焦作,454001
摘    要:目的评价胰激肽原酶联合甲钴胺治疗糖尿病周围神经病变的疗效。方法 80例糖尿病周围神经病变患者随机分为胰激肽原酶加甲钴胺治疗组(治疗组)40例和甲钴胺治疗组(对照组)40例。结果对照组显效率22.5%,总有效率65%;观察组显效率40%,总有效率87.5%。2组间有显著性差异(P<0.05)。结论胰激肽原酶联合甲钴胺治疗糖尿病周围神经病变疗效满意。

关 键 词:胰激肽原酶  糖尿病  周围神经病变  弥可保

Analysis of pancreatic kininogenase and methycobal on diabetic peripheral neuropathy
Zhou Xuehong,Zhao Yanmin,Wang Kai.Analysis of pancreatic kininogenase and methycobal on diabetic peripheral neuropathy[J].Chinese Journal of Practical Neruous Diseases,2011,14(4):21-22.
Authors:Zhou Xuehong  Zhao Yanmin  Wang Kai
Institution:.Department of Endocrinology,the Second People’s Hospital of Jiaozuo,Jiaozuo 454001,China
Abstract:Objective To observe the clinical effect of pancreatic kininogenase and methycobal on diabetic peripheral neuropathy.Methods Eighty cases of patients were divided into two groups.The control group(40 cases)was treated by methycobal.The treatment group(40 cases)was treated by pancreatic kininogenase and methycobal.Results The obvious effective rate of the control group was 22.5%.Total effective rate was 65%.The obvious effective rate of the treatment group was 40%,total effective rate wag 87.5%.There was significant difference between two groups(P<0.05).Conclusion Pancreatic kininogenase and methycobal are effective treating diabetic peripheral neuropathy.
Keywords:Pancreatic kininogenase  Diabetic  Peripheral neuropathy  Methycobal
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号